CLINICAL_TRIALS
trial_result
· 2020-12-09
Clinical Trial Update: Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer [Phase 2]
Summary
Phase 2 clinical trial update for abiraterone in metastatic castration-resistant prostate cancer, with results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Duke University | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-12-09